Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding

NCT01638923 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

339

Enrollment

INDUSTRY

Sponsor class

Conditions

Metrorrhagia

Interventions

DRUG: EV/DNG (Qlaira, Natazia, BAY86-5027)
DRUG: placebo

Sponsor

Bayer